en

PRODUCT DETAIL

Aucilak

Code 0210F
MA number 15/0208/25-S
Product Form: tbl flm 21x875 mg/125 mg (blis. PVDC/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Medreg s.r.o., Czechia
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CR Combinations of penicillins, incl. beta-lactamase
J01CR02 Amoxicillin and enzyme inhibitor
Shelf life: 24
Container: blister PVDC/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 01.07.2025
Validity: 01.07.2030
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Aucilak_tbl flm_06_2025.pdf  
SPC: SPC_Aucilak_tbl flm_06_2025.pdf  
Safety feature Yes
Data update: 02.07.2025
eu-flag.png sk-flag.png